GoodRx Holdings, Inc. - Common Stock (GDRX)

Q1 2021 13F Holders as of 3/31/2021

Type / Class
Equity / Common Stock
Shares outstanding
98.7M
Number of holders
195
Total 13F shares, excl. options
132M
Shares change
+4.52M
Total reported value, excl. options
$5.14B
Value change
+$169M
Put/Call ratio
2.55
Number of buys
128
Number of sells
-84
Price
$39.02

Significant Holders of GoodRx Holdings, Inc. - Common Stock (GDRX) as of Q1 2021

276 filings reported holding GDRX - GoodRx Holdings, Inc. - Common Stock as of Q1 2021.
GoodRx Holdings, Inc. - Common Stock (GDRX) has 195 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 132M shares .
Largest 10 shareholders include Francisco Partners Management, LP (84.7M shares), WELLINGTON MANAGEMENT GROUP LLP (4.54M shares), MORGAN STANLEY (3.56M shares), VANGUARD GROUP INC (3.21M shares), Silver Lake Group, L.L.C. (3.03M shares), TIGER GLOBAL MANAGEMENT LLC (2.15M shares), FMR LLC (2.06M shares), BlackRock Inc. (1.73M shares), GOLDMAN SACHS GROUP INC (1.68M shares), and ZEVENBERGEN CAPITAL INVESTMENTS LLC (1.61M shares).
This table shows the top 195 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.